Spinout Active LTD

Company profile

Indicatrix Crystallography Limited

Indicatrix Crystallography - Crystallising the Uncrystallisable

Crystallising the Uncrystallisable

CRN
12090026
Founded
2019
Age
6

Overview

Browse spinouts
Legal name
INDICATRIX CRYSTALLOGRAPHY LIMITED
Region
North East England
Registered address
33 WALLACE STREET
NEWCASTLE UPON TYNE
UNITED KINGDOM
NE2 4AU
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

1 level 1 ultimate controller
1
Company Active LTD
Indicatrix Crystallography Limited
CRN 12090026
2
Direct and ultimate controller Active LTD

Company events

Reference milestones and recent Companies House filing stream events.

5 events
30 Apr
2027

Accounts due

Accounts Due

Next accounts due date

20 Jul
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Jul
2025

Accounts filed

Accounts

Last accounts made up date

06 Jul
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

07 Jul
2019

Incorporated

Inception

Company registered at Companies House

Spinout profile

4 entries

Company description

Indicatrix Crystallography operates a research firm that provides crystallisation services.

Contract research organisation performing specialised crystallisation of small molecule chemicals

Project impact

Started trading in Oct 2020, first contracts completed early 2021

Indicatrix Crystallography
2019
Indicatrix Crystallography
2019
Indicatrix Crystallography
2019
Indicatrix Crystallography Ltd
2019

Public funding

1 award
First funded
2021
Funded years
2021
Age at first award
2 years

Projects

2021 Collaborative R&D Lead participant

Probing High-Throughput Drug Molecule Crystallisation Methods via Electron Diffraction

1 Dec 2021 to 31 Mar 2022

Awarded
£20,254
Total cost £28,934

Many modern medicines are taken either as a tablet or capsule, in which the drug molecules responsible for giving the medical benefit are often present as small crystals. The form which these molecular crystals take, based on how the drug molecules are arranged within the crystal, can have a significant impact on how quickly the drug is absorbed by the pa...

Product types

Collaborative R&D